› Forums › General Melanoma Community › Breaking Tolerance to Invoke an Immune Response to Cancer (Melanoma)
- This topic has 12 replies, 4 voices, and was last updated 12 years, 3 months ago by boot2aboot.
- Post
-
- February 11, 2012 at 2:08 pm
This post has been in the works for five years. It is with my tenacity and help from researchers around the world I am able to present this paper. It is still in draft form but I thought was important enough to just get it out there. It may be to technical for the average person/patient but, it is well worth downloading and presenting to your oncologist and or medical team.
This post has been in the works for five years. It is with my tenacity and help from researchers around the world I am able to present this paper. It is still in draft form but I thought was important enough to just get it out there. It may be to technical for the average person/patient but, it is well worth downloading and presenting to your oncologist and or medical team.
The gist of the paper is we have responders and non-responders to therapy. WHY?? with the help of Four on the most influential researchers in the Melanoma field, Dr. Craig Slingluff, Dr. Thomas Gajewski, Dr.Kingston Mills, Dr. Jim Allison and others, I was able to put some puzzle pieces together to tell a story. A story that may just save your life
In short, the non-responders may be/are missing the "Danger Signals" inflammatory Cytokines. Why, because their tumors are most likely harboring M2 phenotype macrophages (TAMs) Tumor assisted Macrophages.
But these TAMs have plasticity. This means they can change phenotype based on their miroenviroment. With some coaxing they can be change into M1 macrophages which in turn actiavate the T-cells. This means the patient needs to have therapies that promote M1 and Th1 cells. Well both Dr. Allison and Dr. Mills have discovered ways to do just that.
Please take some time to download and read this historic paper. It just may be the game changer for cancer.
https://www.box.net/s/mzxb1b2o0tue44a3z3xo
I am going end with one slide.
“It is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change.”
~Charles Darwin~
Take Care,
Jimmy B
- Replies
-
-
- February 11, 2012 at 9:16 pm
thanks Jimmy, i will pass this on to someone i know at The Melanoma Institute.
best wishes
James
-
- February 11, 2012 at 9:16 pm
thanks Jimmy, i will pass this on to someone i know at The Melanoma Institute.
best wishes
James
-
- February 11, 2012 at 9:16 pm
thanks Jimmy, i will pass this on to someone i know at The Melanoma Institute.
best wishes
James
-
- February 13, 2012 at 1:02 am
Jimmy, thank you for your groundbreaking efforts to provide solutions to an intricate puzzle. I know that it is not easy to get people to take notice of the work that one has been doing. A long time ago, I wrote extensively about an unrelated health topic and it is only recently that the concepts that I discussed have been accepted.
Best wishes
Frank from Australia
-
- February 13, 2012 at 1:02 am
Jimmy, thank you for your groundbreaking efforts to provide solutions to an intricate puzzle. I know that it is not easy to get people to take notice of the work that one has been doing. A long time ago, I wrote extensively about an unrelated health topic and it is only recently that the concepts that I discussed have been accepted.
Best wishes
Frank from Australia
-
- February 13, 2012 at 1:02 am
Jimmy, thank you for your groundbreaking efforts to provide solutions to an intricate puzzle. I know that it is not easy to get people to take notice of the work that one has been doing. A long time ago, I wrote extensively about an unrelated health topic and it is only recently that the concepts that I discussed have been accepted.
Best wishes
Frank from Australia
-
- February 13, 2012 at 3:07 am
Wondering how this information can be used now? I was a non-responder to Ipilumamab and recently read an interview given by Allison. In the interview, they asked him why he thought some people were responders and others were not. My take of what he said (can’t find the article right now) was that you needed some type of cell death to create inflammation which in turn would help the immune system recognize the tumor or cancer. I took the article to my oncologist and she didn’t really seem to have an idea on what to do with the information. It’s frustrating to say the least. My treatment options are somewhat limited as I am not HLA positive. Starting to look to alternatives but I would be interested in perusing this avenue if you have any suggestions on how to do so. -
- February 13, 2012 at 3:07 am
Wondering how this information can be used now? I was a non-responder to Ipilumamab and recently read an interview given by Allison. In the interview, they asked him why he thought some people were responders and others were not. My take of what he said (can’t find the article right now) was that you needed some type of cell death to create inflammation which in turn would help the immune system recognize the tumor or cancer. I took the article to my oncologist and she didn’t really seem to have an idea on what to do with the information. It’s frustrating to say the least. My treatment options are somewhat limited as I am not HLA positive. Starting to look to alternatives but I would be interested in perusing this avenue if you have any suggestions on how to do so. -
- February 13, 2012 at 3:07 am
Wondering how this information can be used now? I was a non-responder to Ipilumamab and recently read an interview given by Allison. In the interview, they asked him why he thought some people were responders and others were not. My take of what he said (can’t find the article right now) was that you needed some type of cell death to create inflammation which in turn would help the immune system recognize the tumor or cancer. I took the article to my oncologist and she didn’t really seem to have an idea on what to do with the information. It’s frustrating to say the least. My treatment options are somewhat limited as I am not HLA positive. Starting to look to alternatives but I would be interested in perusing this avenue if you have any suggestions on how to do so.
-
- You must be logged in to reply to this topic.